Source: FierceBiotechIT

Accelerated Pharma: Accelerated Pharma puts the brakes on IPO

After nearly a year and three term revisions, Accelerated Pharma is pulling its initial public offering.

Read full article »
Accelerated Pharma's Competitors | Accelerated Pharma's News | Accelerated Pharma's Financials
Stay up-to-date with the latest news on Accelerated Pharma, Inc.
Annual Revenue
$100K-5.0M
Employees
1-25
Michael Fonstein's photo - CEO of Accelerated Pharma, Inc.

CEO

Michael Fonstein

CEO Approval Rating

69/100

Read more
Stay up-to-date with the latest news on Accelerated Pharma, Inc.